Abstracts (HTML) List of Authors

Obser, Tobias

Degradation of VWD Type 2B Variants by ADAMTS-13 in Simulated Circulation
Functional and Structural Properties of the 2nd Gain-of-Function Variant in the C4 Domain of von Willebrand Factor

Ochs, Sebastian

Fit for Life Fitness-App – sicheres und effektives Training in Fitnesseinrichtungen

Oldenburg, J.

FXIII Protein Inhibitor against the FXIII-A Subunit in an 8-Year-Old Boy with Inherited Severe Factor XIII Deficiency Complicated by Multiple Intracerebral Cavernomas

Oldenburg, Johannes

Provision of Psychological Services in Hemophilia Treatment Postulated under the Guidelines of the WFH and the GTH—But Also in Demand? Experiences from the Hemophilia Center Bonn
Hämophilietherapie im Wandel: Auswirkungen auf das Gerinnungslabor
Successful Embryo Transfer and Pregnancy with Donated Egg in a Female with Severe FXIII Deficiency and Climacterium Praecox
Alpha-2 Macroglobulin: A Novel Putative Interacting Partner of FXIII/FXIIIB Subunit?
Dokumentationsqualität und Therapieadhärenz: Daten der Haemoassist-Community
Molecular Profiling of Fetal and Adult Liver Sinusoidal Endothelial Cells: A F8 Secreting Cell
AIM-Active-Studie – Hintergrund – Ziel – Design
LumiTope: Toward Improving the Performance of Identification of Antifactor VIII Antibodies in Congenital and Acquired Hemophilia A
AHEAD International and German Studies: Effectiveness, Safety, and Quality of Life Outcomes in Patients with Hemophilia A Treated with Antihemophilic Factor (Recombinant) in a Real-World Setting Over 5 Years
Inversions at Xq28 Causing Hemophilia A Are Associated with Specific
Impact of Novel Missense Mutation (p. Arg510Cys) in the FGA Gene Resulting in Dysfibrinogenemia

Oldenburg, Johannnes

Over Expression of Specific Transcription Factors to Boost FVIII Expression
Analyzing intracellular F8 mRNA and Protein of a Methionine Missense Mutation (c.[2T>G];[0]) in a Patient-Specific IPS Cell Model

Olivieri, Martin

Emicizumab – Erfahrungen zur Anwendung bei Kindern mit Hämophilie und Hemmkörpern
Familial Multiple Coagulation Factor Deficiencies: Follow-up Analyses

on behalf of the ABIRISK consortium,

Signature of the Antibody Response to FVIII

on behalf of the ABIRISK Consortium,

Nonneutralizing Factor VIII Antibodies as a Marker for Inhibitor Development in a Longitudinal Cohort of Hemophilia A Patients

Orlowski, A.

Responsiveness of PBMCs Isolated from Healthy Individuals toward rFVIII and rFVIIIFc

Orlowski, Aleksander

Characterization of FVIII Pharmacokinetics in Hemophilia A Patients with or without Nonneutralizing FVIII Antibodies
Signature of the Antibody Response to FVIII
Nonneutralizing Factor VIII Antibodies as a Marker for Inhibitor Development in a Longitudinal Cohort of Hemophilia A Patients